Clinical trials
Completed Phase 1/2 Mesothelioma, Malignant trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2015 | 2 |
| 2017 | 3 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University Health Network, Toronto | 2 |
| University Hospital, Antwerp | 2 |
| Armando Santoro, MD | 1 |
| CRISPR Therapeutics AG | 1 |
| CanBas Co. Ltd. | 1 |
| Kissei Pharmaceutical Co., Ltd. | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
| RS Oncology LLC | 1 |
| Sumitomo Pharma Co., Ltd. | 1 |
| The Netherlands Cancer Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mesothelioma, Malignant | 14 |
| Mesothelioma | 3 |
| Carcinoma, Renal Cell | 2 |
| Breast Neoplasms | 1 |
| Carcinoma | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Colorectal Neoplasms | 1 |
| Esophageal Neoplasms | 1 |
| Glioblastoma | 1 |
| Pleural Effusion, Malignant | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.